共 39 条
- [31] Mundell AC., New therapeutic agents in veterinary dermatology, Vet Clin North Am Small Anim Prac, 20, pp. 1541-1556, (1990)
- [32] Saag MS, Dismukes WE., Azole antifungal agents: Emphasis on new triazoles, Antimicrob Agents Chemother, 32, pp. 1-8, (1988)
- [33] Vanden Bossche H., Biochemical targets for antifungal azole derivatives: Hypothesis on the mode of action, Curr Top Med My-col, 1, pp. 313-351, (1985)
- [34] Baily EM, Krakovsky DJ, Et al., The triazole antifungal agents: A review of itraconazole and fluconazole, Pharmacotherap, 10, pp. 146-153, (1990)
- [35] Hanger DP, Land G., Marriott MS, Et al., The activity and selectivity of the novel, bis triazole UK‐49858 for fungal sterol 14‐alpha demethylation. Program and Abstracts of the 25th Intersci‐ence Conference on Antimicrobial Agents and Chemotherapy, (1985)
- [36] Bargers M., Van de Ven MA., Degenerative changes in fungi after itraconazole treatment, Rev Infec Dis, 9, pp. 533-542, (1987)
- [37] Van Cauteren H., Heykants JDE, Caster R., Et al., Itraconazole: Pharmacologic studies in animals and humans, Rev Infect Dis, 9, (1987)
- [38] Brooks DE, Legendre AM, Gum GG, Et al., The treatment of canine ocular blastomycosis with systemically administered itraconazole, Prog Vet Compar Ophthal, 1, pp. 263-268, (1991)
- [39] Ringel SM., New antifungal agents for the systemic mycoses, Mycopathologia, 109, pp. 75-87, (1990)